LIFR and nonpapillary renal cell carcinoma: Similarly, leukemia inhibitory factor receptor (LIFR) attenuates ccRCC metastasis by upregulating Hippo signaling pathway kinase activity, which inhibits YAP expression (Lei et al., 2018).